61.
62.
Why obesity drugs work better for some people: these genes hold clues
(feeds.nature.com)
63.
Genetics reveal why people respond differently to GLP-1 weight-loss drugs
(feeds.nature.com)
64.
Gen Z wants their job to cover GLP-1 weight-loss drugs, survey suggests
(feeds.feedburner.com)
66.
A new weight-loss pill is here, and it could reshape the GLP-1 market
(feeds.feedburner.com)
67.
FDA Approves Eli Lilly’s GLP-1 Pill
(wired.com)
68.
FDA Approves Eli Lilly's GLP-1 Pill
(wired.com)
69.
70.
71.
72.
Ro CEO on the next phase of the Ozempic boom
(feeds.feedburner.com)
73.
Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists
(news.ycombinator.com)
74.
Heart Attack and Stroke Risk Jumps When People Stop Taking GLP-1s
(news.ycombinator.com)
75.
76.
Is It Safe to Inject Gray-Market Chinese Peptides?
(futurism.com)
77.
Quitting Ozempic Could Hit Your Heart Hard, Study Finds
(gizmodo.com)
78.
Your Off-Brand GLP-1 Is Dirtier Than You Think
(gizmodo.com)
79.
Why smaller portions are the biggest restaurant trend right now
(feeds.feedburner.com)